[Renal effect of treatment for heart failure]

Zhiying Zhang Rasmussen1, Toke Barfod, Jakob Klit

  • 1Forhåbningsholms Alle 17A, 2. tv., DK-Frederiksberg C. zhiyingzhang@gmail.com

Ugeskrift for Laeger
|March 5, 2009
PubMed

Insights

Intensive diuretic and ACE inhibitor treatment can impair kidney function in heart failure patients. Stopping or reducing these medications may restore normal renal function, aiding patient recovery.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Cardiorenal syndrome is a complex condition involving heart and kidney dysfunction.
  • Management of heart failure often involves diuretics and ACE inhibitors.
  • Renal function monitoring is crucial during such treatments.

Observation:

  • A 66-year-old male with heart failure experienced normal renal function prior to intensive therapy.
  • The patient underwent treatment with diuretics and an angiotensin-converting enzyme (ACE) inhibitor.
  • Renal function declined during this intensive treatment regimen.

Findings:

  • Cessation or dose reduction of the ACE inhibitor and diuretics led to normalization of renal function.
  • This suggests a potential iatrogenic cause for the cardiorenal syndrome in this case.
  • The findings highlight the delicate balance of cardiorenal physiology.

Implications:

  • Clinicians should carefully monitor renal function in heart failure patients receiving diuretics and ACE inhibitors.
  • Consideration should be given to adjusting medication dosages or discontinuing therapy if renal function deteriorates.
  • Further research is warranted to elucidate the mechanisms of ACE inhibitor-induced cardiorenal effects.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...